This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Zogenix, Inc.
ZGNX : NASDAQ :
$1.27 | %
Today's Range: 1.25 - 1.30
Avg. Daily Volume: 0
10/24/14 - 3:59 PM ET

PEER GROUP: Pharmaceuticals



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
ZGNX ZOGENIX INC 1.30 183.36 n/m 33.92 0.15
MSLI MERUS LABS INTERNATIONAL INC 1.29 99.33 n/m 29.27 26.75
OCRX OCERA THERAPEUTICS INC 4.96 97.92 n/m 0.16 n/a
ANIP ANI PHARMACEUTICALS INC 27.85 315.09 48.02 35.92 483.88
POZN POZEN INC 8.14 256.64 n/m 22.22 314.78
ECYT ENDOCYTE INC 5.85 243.07 21.67 100.31 73.35
AMPE AMPIO PHARMACEUTICALS INC 4.00 207.89 n/m 0.06 18.00
ALIM ALIMERA SCIENCES INC 4.82 207.13 n/m 5.97 3233.51
DRRX DURECT CORP 1.32 147.31 n/m 18.13 19.58
CRME CARDIOME PHARMA CORP 8.07 120.71 n/m 19.60 6142.99
ARDM ARADIGM CORP 7.89 116.05 n/m 28.07 2673.32
The peer group comparison is based on Major Pharmaceuticals companies of comparable size.

Price Earnings Comparison

ZGNX Ind Avg S&P 500
n/m 38.74 18.06
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs